RCVRN
gene geneOn this page
Summary
RCVRN (recoverin, HGNC:9937) is a protein-coding gene on chromosome 17p13.1, encoding Recoverin (P35243). Acts as a calcium sensor and regulates phototransduction of cone and rod photoreceptor cells.
This gene encodes a member of the recoverin family of neuronal calcium sensors. The encoded protein contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy.
Source: NCBI Gene 5957 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 23 total
- MANE Select transcript:
NM_002903
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9937 |
| Approved symbol | RCVRN |
| Name | recoverin |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000109047 |
| Ensembl biotype | protein_coding |
| OMIM | 179618 |
| Entrez | 5957 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000226193, ENST00000570909
RefSeq mRNA: 1 — MANE Select: NM_002903
NM_002903
CCDS: CCDS11151
Canonical transcript exons
ENST00000226193 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000684918 | 9900989 | 9901100 |
| ENSE00000855139 | 9904800 | 9905271 |
| ENSE00001294803 | 9896320 | 9898204 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 78.13.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 5.6828 / max 2585.5624, expressed in 17 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164511 | 5.4592 | 14 |
| 164510 | 0.1072 | 8 |
| 164506 | 0.0495 | 6 |
| 164509 | 0.0299 | 5 |
| 164512 | 0.0142 | 5 |
| 164507 | 0.0115 | 4 |
| 164508 | 0.0113 | 3 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.13 | gold quality |
| type B pancreatic cell | CL:0000169 | 73.33 | gold quality |
| olfactory bulb | UBERON:0002264 | 73.30 | gold quality |
| retina | UBERON:0000966 | 71.70 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 71.69 | gold quality |
| pineal body | UBERON:0001905 | 68.17 | silver quality |
| cortical plate | UBERON:0005343 | 68.03 | gold quality |
| endometrium epithelium | UBERON:0004811 | 67.67 | gold quality |
| right frontal lobe | UBERON:0002810 | 66.10 | gold quality |
| cingulate cortex | UBERON:0003027 | 65.53 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 65.22 | gold quality |
| granulocyte | CL:0000094 | 65.04 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.67 | gold quality |
| diaphragm | UBERON:0001103 | 63.03 | gold quality |
| thymus | UBERON:0002370 | 62.89 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 62.45 | gold quality |
| mononuclear cell | CL:0000842 | 61.52 | gold quality |
| monocyte | CL:0000576 | 61.47 | gold quality |
| leukocyte | CL:0000738 | 61.25 | gold quality |
| neocortex | UBERON:0001950 | 61.19 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 60.84 | gold quality |
| frontal cortex | UBERON:0001870 | 60.71 | gold quality |
| omental fat pad | UBERON:0010414 | 60.57 | gold quality |
| peritoneum | UBERON:0002358 | 60.56 | gold quality |
| left uterine tube | UBERON:0001303 | 60.34 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 60.17 | gold quality |
| cerebral cortex | UBERON:0000956 | 59.64 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 59.51 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 59.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 59.48 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 11662.95 |
| E-MTAB-11121 | yes | 7666.83 |
| E-GEOD-137537 | yes | 4478.45 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NR1D1, NR2E3, RBPJ
miRNA regulators (miRDB)
34 targeting RCVRN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-10226 | 98.25 | 66.50 | 811 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-27B-5P | 97.34 | 66.55 | 549 |
| HSA-MIR-3139 | 96.68 | 66.77 | 652 |
| HSA-MIR-28-5P | 96.16 | 66.12 | 579 |
Literature-anchored findings (GeneRIF, showing 11)
- recoverin has a pathological role in cancer-associated retinopathy (PMID:12596918)
- There are cis-acting elements in the 5’ non-coding region of the recoverin gene that are involved in the activation and suppression of gene expression. (PMID:12789533)
- Human recoverin is expressed in SCLC cells cultured from an anti-recoverin antibody-negative patient with CAR. KK0206 might be important for further research on SCLC related retinopathy. (PMID:17374419)
- A GRK1 region close to its C-terminus also seemed to be the binding site for S-modulin/recoverin. (PMID:18266817)
- Aberrant hypomethylation of the recoverin gene region, overlapping the promoter up-stream of the first exon and the first exon itself, is involved in the aberrant expression of recoverin in tumor cells. (PMID:20812967)
- C39D substitution reduces alpha-helical content, decreases thermal stability and suppresses membrane association. (PMID:21344177)
- Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands. (PMID:26584024)
- High RCVRN expression is associated with renal tumors. (PMID:26813565)
- these data confirm the scaffolding function of several cluster-forming residues and point to their critical role in supporting physiological activity of recoverin (PMID:31288444)
- Recoverin (Rec) is a prototypical calcium sensor protein primarily expressed in the vertebrate retina. The binding of two Ca(2+) ions to the functional EF-hand motifs induces the extrusion of a myristoyl group that increases the affinity of Rec for the membrane and leads to the formation of a complex with rhodopsin kinase (GRK1). (PMID:31658639)
- Serum anti-recoverin antibodies is found in elderly patients with retinitis pigmentosa and cancer. (PMID:32043815)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rcvrn3 | ENSDARG00000009637 |
| danio_rerio | rcvrn2 | ENSDARG00000019902 |
| mus_musculus | Rcvrn | ENSMUSG00000020907 |
| rattus_norvegicus | Rcvrn | ENSRNOG00000003633 |
| drosophila_melanogaster | CG7646 | FBGN0036926 |
| drosophila_melanogaster | CG5890 | FBGN0039380 |
| caenorhabditis_elegans | ncs-2 | WBGENE00003564 |
| caenorhabditis_elegans | WBGENE00015867 |
Paralogs (14): CLXN (ENSG00000034239), GUCA1A (ENSG00000048545), NCALD (ENSG00000104490), NCS1 (ENSG00000107130), GUCA1B (ENSG00000112599), KCNIP3 (ENSG00000115041), HPCAL1 (ENSG00000115756), HPCAL4 (ENSG00000116983), KCNIP2 (ENSG00000120049), HPCA (ENSG00000121905), GUCA1C (ENSG00000138472), VSNL1 (ENSG00000163032), KCNIP1 (ENSG00000182132), KCNIP4 (ENSG00000185774)
Protein
Protein identifiers
Recoverin — P35243 (reviewed: P35243)
Alternative names: Cancer-associated retinopathy protein
All UniProt accessions (1): P35243
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a calcium sensor and regulates phototransduction of cone and rod photoreceptor cells. Modulates light sensitivity of cone photoreceptor in dark and dim conditions. In response to high Ca(2+) levels induced by low light levels, prolongs RHO/rhodopsin activation in rod photoreceptor cells by binding to and inhibiting GRK1-mediated phosphorylation of RHO/rhodopsin. Plays a role in scotopic vision/enhances vision in dim light by enhancing signal transfer between rod photoreceptors and rod bipolar cells. Improves rod photoreceptor sensitivity in dim light and mediates response of rod photoreceptors to facilitate detection of change and motion in bright light.
Subunit / interactions. Homodimer; disulfide-linked. Homodimerization is caused by prolonged intense illumination. May form a complex composed of RHO, GRK1 and RCVRN in a Ca(2+)-dependent manner; RCVRN prevents the interaction between GRK1 and RHO. Interacts (via C-terminus) with GRK1 (via N-terminus); the interaction is Ca(2+)-dependent.
Subcellular location. Photoreceptor inner segment. Cell projection. Cilium. Photoreceptor outer segment. Photoreceptor outer segment membrane. Perikaryon.
Tissue specificity. Retina and pineal gland.
Post-translational modifications. The N-terminal glycine is linked to one of four different types of acyl groups. The most abundant is myristoleate (14:1), but 14:0, 14:2, and 12:0 acyl residues are also present. The Ca(2+) induced exposure of the myristoyl group, known as the calcium-myristoyl switch, promotes RCVRN binding to the photoreceptor cell membranes only when intracellular Ca(2+) concentration is high. Oxidation on Cys-39 occurs in response to prolonged intense illumination and results in the formation of disulfide homodimers, and to a lesser extent disulfide-linked heterodimers.
Domain organisation. EF-hand 2 and EF-hand 3 domains are the low-affinity and the high-affinity calcium binding sites, respectively. EF-hand 1 and EF-hand 4 domains do not bind calcium due to substitutions that disrupt their respective Ca(2+) binding loops. The cooperative binding of calcium to the EF-hand 2 domain following EF-hand 3 domain calcium binding requires myristoylation. Calcium binding to the 2 EF-hand domains induces exposure of the myristoyl group through a protein conformation change, this process known as the calcium-myristoyl switch facilitates binding to photoreceptor cell membranes.
Similarity. Belongs to the recoverin family.
RefSeq proteins (1): NP_002894* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR028846 | Recoverin | Family |
Pfam: PF13499, PF13833
UniProt features (37 total): helix 11, binding site 10, domain 4, strand 4, initiator methionine 1, chain 1, site 1, modified residue 1, lipid moiety-binding region 1, disulfide bond 1, turn 1, region of interest 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2D8N | X-RAY DIFFRACTION | 2.2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P35243-F1 | 84.11 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 192 (interaction with grk1)
Ligand- & substrate-binding residues (10): 80; 85; 110; 112; 114; 116; 121; 74; 76; 78
Post-translational modifications (2): 39, 2
Disulfide bonds (1): 39
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade |
MSigDB gene sets: 108 (showing top):
GOBP_PHOTOTRANSDUCTION, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, MODULE_88, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOCC_NEURON_PROJECTION, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, AGCTCCT_MIR28
GO Biological Process (5): signal transduction (GO:0007165), visual perception (GO:0007601), phototransduction (GO:0007602), regulation of signal transduction (GO:0009966), regulation of calcium ion transport (GO:0051924)
GO Molecular Function (3): calcium ion binding (GO:0005509), calcium sensitive guanylate cyclase activator activity (GO:0008048), metal ion binding (GO:0046872)
GO Cellular Component (6): photoreceptor outer segment (GO:0001750), photoreceptor inner segment (GO:0001917), dendrite (GO:0030425), perikaryon (GO:0043204), membrane (GO:0016020), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| The phototransduction cascade | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| signal transduction | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of light stimulus | 1 |
| detection of light stimulus | 1 |
| regulation of cell communication | 1 |
| regulation of signaling | 1 |
| regulation of response to stimulus | 1 |
| calcium ion transport | 1 |
| regulation of metal ion transport | 1 |
| metal ion binding | 1 |
| guanylate cyclase activator activity | 1 |
| cation binding | 1 |
| photoreceptor cell cilium | 1 |
| neuron projection | 1 |
| dendritic tree | 1 |
| neuronal cell body | 1 |
Protein interactions and networks
STRING
2320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RCVRN | GRK7 | Q8WTQ7 | 955 |
| RCVRN | RHO | P08100 | 941 |
| RCVRN | GRK1 | Q15835 | 938 |
| RCVRN | CRX | O43186 | 907 |
| RCVRN | GUCY2D | Q02846 | 850 |
| RCVRN | SAG | P10523 | 832 |
| RCVRN | AMPH | P49418 | 819 |
| RCVRN | OTX2 | P32243 | 805 |
| RCVRN | BIN1 | O00499 | 782 |
| RCVRN | VSX2 | P58304 | 782 |
| RCVRN | ZIC4 | Q8N9L1 | 763 |
| RCVRN | GAD2 | Q05329 | 758 |
| RCVRN | KCNC1 | P48547 | 756 |
| RCVRN | ARR3 | P36575 | 751 |
| RCVRN | PNMA2 | Q9UL42 | 735 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ASF1B | HAT1 | psi-mi:“MI:0914”(association) | 0.640 |
| RCVRN | RAB9A | psi-mi:“MI:0914”(association) | 0.530 |
| COMMD10 | VPS26C | psi-mi:“MI:0914”(association) | 0.530 |
| ARL4D | IFI30 | psi-mi:“MI:0914”(association) | 0.530 |
| CXXC4 | RCVRN | psi-mi:“MI:0915”(physical association) | 0.400 |
| IL15RA | RCVRN | psi-mi:“MI:0915”(physical association) | 0.370 |
| RCVRN | SMAD3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TGFBR2 | RCVRN | psi-mi:“MI:0915”(physical association) | 0.370 |
| RCVRN | GIT2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ASF1B | HAT1 | psi-mi:“MI:0914”(association) | 0.350 |
| PQBP1 | RCVRN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): SCRN3 (Affinity Capture-MS), RAB9A (Affinity Capture-MS), C11orf73 (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Reconstituted Complex), GRK5 (Affinity Capture-Western), GRK6 (Affinity Capture-Western), CAV1 (Affinity Capture-Western), SCRN3 (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), C11orf73 (Affinity Capture-MS), RAB9A (Affinity Capture-MS)
ESM2 similar proteins: G5EDN6, O73761, P0CM54, P0CM55, P21457, P22728, P25296, P28470, P29104, P34057, P35243, P35332, P42322, P43080, P43081, P46065, P48451, P61022, P61023, P62760, P62761, P62762, P62763, P62764, P63098, P63099, P63100, P79880, P87072, Q24214, Q2TBI5, Q4R5F7, Q54MF3, Q55G87, Q5R6S5, Q5R7F0, Q5RD22, Q63810, Q63811, Q6BWS8
Diamond homologs: A0JN54, A8JQ65, B3LXF2, B3NYS4, B4I4Y1, B4JHJ7, B4K6T8, B4PRE2, B4R0A5, D3YWQ0, D3ZEY4, F1MAB7, O08560, O75912, O88673, P0CM54, P0CM55, P20192, P23743, P25296, P34057, P34125, P35243, P49619, P49620, P49621, P51556, P52429, P52824, P87072, Q01583, Q03603, Q09103, Q10024, Q13574, Q39017, Q6BWS8, Q6CGE6, Q6DT37, Q6FLU4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
369 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:9901002:T:A | donor_gain | 1.0000 |
| 17:9901013:T:TA | donor_gain | 1.0000 |
| 17:9901014:C:A | donor_gain | 1.0000 |
| 17:9901096:ATAGC:A | acceptor_gain | 1.0000 |
| 17:9901097:TAGC:T | acceptor_gain | 1.0000 |
| 17:9901098:AGC:A | acceptor_gain | 1.0000 |
| 17:9901098:AGCC:A | acceptor_loss | 1.0000 |
| 17:9901099:GC:G | acceptor_gain | 1.0000 |
| 17:9901100:CC:C | acceptor_gain | 1.0000 |
| 17:9901101:C:CC | acceptor_gain | 1.0000 |
| 17:9901101:CT:C | acceptor_loss | 1.0000 |
| 17:9901102:T:C | acceptor_loss | 1.0000 |
| 17:9901103:G:C | acceptor_gain | 1.0000 |
| 17:9901107:C:CT | acceptor_gain | 1.0000 |
| 17:9904796:TGAC:T | donor_loss | 1.0000 |
| 17:9904797:GAC:G | donor_loss | 1.0000 |
| 17:9904798:A:AC | donor_gain | 1.0000 |
| 17:9904798:ACC:A | donor_loss | 1.0000 |
| 17:9904799:C:CC | donor_gain | 1.0000 |
| 17:9904819:T:TA | donor_gain | 1.0000 |
| 17:9900891:G:A | donor_gain | 0.9900 |
| 17:9900984:TTCAC:T | donor_loss | 0.9900 |
| 17:9900985:TCA:T | donor_loss | 0.9900 |
| 17:9900986:CACC:C | donor_loss | 0.9900 |
| 17:9900987:ACC:A | donor_loss | 0.9900 |
| 17:9900988:C:CA | donor_loss | 0.9900 |
| 17:9900988:CCAT:C | donor_gain | 0.9900 |
| 17:9901010:A:AC | donor_gain | 0.9900 |
| 17:9901011:C:CC | donor_gain | 0.9900 |
| 17:9901103:G:GC | acceptor_gain | 0.9900 |
AlphaMissense
1345 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:9898183:A:G | F172S | 0.998 |
| 17:9901030:C:G | R151P | 0.998 |
| 17:9904863:G:C | F106L | 0.998 |
| 17:9904863:G:T | F106L | 0.998 |
| 17:9904865:A:G | F106L | 0.998 |
| 17:9904969:C:G | R71P | 0.998 |
| 17:9904971:G:C | F70L | 0.998 |
| 17:9904971:G:T | F70L | 0.998 |
| 17:9904973:A:G | F70L | 0.998 |
| 17:9904871:A:G | W104R | 0.997 |
| 17:9904871:A:T | W104R | 0.997 |
| 17:9904932:G:C | F83L | 0.997 |
| 17:9904932:G:T | F83L | 0.997 |
| 17:9904933:A:G | F83S | 0.997 |
| 17:9904934:A:G | F83L | 0.997 |
| 17:9905035:A:G | F49S | 0.997 |
| 17:9905076:G:C | F35L | 0.997 |
| 17:9905076:G:T | F35L | 0.997 |
| 17:9905078:A:G | F35L | 0.997 |
| 17:9898182:G:C | F172L | 0.996 |
| 17:9898182:G:T | F172L | 0.996 |
| 17:9898184:A:G | F172L | 0.996 |
| 17:9901100:C:G | A128P | 0.996 |
| 17:9904831:A:T | I117N | 0.996 |
| 17:9904858:A:G | L108P | 0.996 |
| 17:9904869:C:A | W104C | 0.996 |
| 17:9904869:C:G | W104C | 0.996 |
| 17:9904915:G:T | A89D | 0.996 |
| 17:9904921:A:T | V87D | 0.996 |
| 17:9904972:A:G | F70S | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000581302 (17:9906782 G>A), RS1000697346 (17:9906988 C>T), RS1000783060 (17:9895837 A>T), RS1000838758 (17:9896368 T>A), RS1001053550 (17:9896032 G>A,C), RS1001353468 (17:9902147 C>G,T), RS1001546157 (17:9906235 A>C), RS1002200003 (17:9902600 G>T), RS1002258819 (17:9897230 T>C), RS1003045879 (17:9898281 A>G), RS1003183970 (17:9899799 T>A,C), RS1003210655 (17:9905528 T>C), RS1003382947 (17:9899361 A>G), RS1003505720 (17:9905377 G>A,C,T), RS1003854930 (17:9902506 C>A)
Disease associations
OMIM: gene MIM:179618 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, decreases expression | 3 |
| tetrabromobisphenol S | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| bisphenol S | affects cotreatment, increases methylation | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Aluminum | affects binding, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Formaldehyde | decreases expression | 1 |
| Potassium Chloride | decreases response to substance, increases expression | 1 |
| Dronabinol | decreases response to substance, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.